Anastrozole
Anastrozole is a non-steroidal aromatase inhibitor used in research contexts to reduce conversion of androgens to estrogen. This listing is 100 tablets × 1 mg with a label dose of 1 mg/day and an approximate 2-day half-life. It does not itself aromatize; it is studied as an estrogen-synthesis blocker. Lipid changes and joint dryness are the usual monitoring themes in published protocols. Presented for laboratory research documentation only. Not for human consumption.
Identity, strength, and pack size on this listing follow the supplied product photography. Batch-specific laboratory documentation can be requested through the contact form. For laboratory research documentation only. Not for human consumption, diagnostic, or therapeutic use.
Anastrozole is a non-steroidal aromatase inhibitor used in research contexts to reduce conversion of androgens to estrogen. This listing is 100 tablets × 1 mg with a label dose of 1 mg/day and an approximate 2-day half-life. It does not itself aromatize; it is studied as an estrogen-synthesis blocker. Lipid changes and joint dryness are the usual monitoring themes in published protocols. Presented for laboratory research documentation only. Not for human consumption.
Store at 20–25°C (room temperature). Protect from direct sunlight and freezing. Restricted laboratory access — keep out of reach of children and unauthorized users.
innov8pharma presents this material for laboratory documentation. Certificate of Analysis files can be requested per batch. Not for human consumption.
| Compound | Anastrozole (Arimidex) |
|---|---|
| Form | Oral tablets |
| Pack | 100 tablets × 1mg |
| Label dosage range | 1 mg/day |
| Water Retention | No |
| Aromatization | No (aromatase inhibitor) |
| Half Life | 2 days |
| HBR | No |
| Acne | Rarely |
| Hepatotoxicity | Low |
| Storage | 20–25°C |